Tamarack Advisers’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-600,000
Closed -$5.92M 18
2023
Q3
$5.92M Buy
+600,000
New +$6.25M 3.83% 6
2022
Q4
Sell
-4,000
Closed -$30K 48
2022
Q3
$30K Buy
+4,000
New +$39.4K 0.02% 45
2022
Q2
Sell
-3,000
Closed -$33K 54
2022
Q1
$33K Sell
3,000
-7,000
-70% -$92.2K 0.02% 46
2021
Q4
$60K Buy
10,000
+5,000
+100% +$66.8K 0.02% 47
2021
Q3
$250K Buy
+5,000
New +$70.9K 0.08% 39
2021
Q2
Sell
-3,000
Closed -$3K 76
2021
Q1
$3K Sell
3,000
-2,000
-40% -$32.6K ﹤0.01% 71
2020
Q4
$1.88M Buy
+5,000
New +$81.6K 0.39% 37

Other funds holding VTRS

Tamarack Advisers's VTRS Position: Q4 2023 in Review

Tamarack Advisers sold out of Viatris (VTRS) in Q4 2023, closing a stake of 675,000 shares — an estimated $6.66M sold.

Tamarack Advisers first reported a position in VTRS in Q4 2019 and held it in 15 quarters. The position peaked at $14.4M in Q1 2023. 1,016 funds tracked by Wall St. Rank hold VTRS as of Q4 2023.

  • Tamarack Advisers reported no remaining Viatris position as of Q4 2023 after selling out during the quarter.
  • Tamarack Advisers sold 675,000 Viatris shares in Q4 2023, an estimated $6.66M.
  • Tamarack Advisers first reported a position in Viatris in Q4 2019 and held it in 15 quarters.
  • Tamarack Advisers's Viatris position peaked at $14.4M in Q1 2023.
  • 1,016 funds tracked by Wall St. Rank held Viatris as of Q4 2023.

Based on Tamarack Advisers's 13F filing for Q4 2023, filed 9 Feb 2024.